Plexin-B1 mutations in prostate cancer. - Wikidata - wikimedia - TriplyDB

Plexin-B1 mutations in prostate cancer.

Plexin-B1 mutations in prostate cancer.

http://www.wikidata.org/entity/Q30480866

about

Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPase Effect of cancer-associated mutations in the PlexinB1 gene Guidance molecules in lung cancer Neuropilins: expression and roles in the epithelium Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation Insights into Oncogenic Mutations of Plexin-B1 Based on the Solution Structure of the Rho GTPase Binding Domain A Dual Binding Mode for RhoGTPases in Plexin Signalling ARF-GEF cytohesin-2/ARNO regulates R-Ras and α5-integrin recycling through an EHD1-positive compartment Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.VEGF targets the tumour cell.CanProVar: a human cancer proteome variation database.Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysis Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors A cytosolic juxtamembrane interface modulates plexin A3 oligomerization and signal transduction.Loss of plexin-B3 in hepatocellular carcinoma.The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer Plexin-B1 and semaphorin 4D cooperate to promote perineural invasion in a RhoA/ROK-dependent manner.The role of semaphorins and their receptors in gliomas The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer.Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.Ligand-independent activation of MET through IGF-1/IGF-1R signaling.Semaphorins and their receptors in lung cancer.Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.Roles of Sema4D and Plexin-B1 in tumor progression c-MET as a potential therapeutic target and biomarker in cancer.Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.Class 3 semaphorins as a therapeutic target.The complexity of prostate cancer: genomic alterations and heterogeneity.Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression.Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2.Plexin B1 inhibits integrin-dependent pp125FAK and Rho activity in melanoma.A role for class 3 semaphorins in prostate cancer.Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway.Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.MNAzymes, a versatile new class of nucleic acid enzymes that can function as biosensors and molecular switches.

P2860

Q24294818-B7B15F5E-F871-4F9B-8847-A5D9C87DA010 Q24306887-FE4DB582-9C68-46B7-A08E-526FA2C2893B Q24598659-BF6F454C-8236-4977-B477-121CD89FEA7A Q26998786-3BB423AC-EF30-4064-9295-5ADC244B9D54 Q27320214-EE3E57EA-412F-4776-9BFC-02C7B829EBBD Q27649860-A7D36609-D365-42D4-8C5D-0E43815E2613 Q27673776-9421C29A-8785-4631-9D81-CD4CA437DC16 Q30361215-800A58B4-FEC2-48A9-AD85-4B6925647513 Q31130674-C190ABB9-A43E-4F62-B004-A5160E260573 Q33573324-23A8FE2D-178D-42AF-8596-E2FFE9BB2438 Q33691397-BEEA4B31-0E27-4E57-A9EC-B6F8ECF8A0FB Q33741045-19A092B2-B47C-46D4-AF28-3851DE162242 Q34184661-06B31BB0-0A3C-4FD2-8E01-352432E0224A Q34452275-CD898413-E76D-46DE-A381-B465BBBBACAA Q34856542-BC34517B-30D9-4354-9C69-E4A85A223507 Q35159658-057B6177-0292-4912-A0ED-CBC598BDE2D1 Q35218537-3BB64199-66E0-4A4E-8D76-545F7672BDFF Q35615400-240993F3-BEBE-4C20-894E-8510A6D94E8C Q35933921-C83F40FE-DD10-4ABF-B717-C6DF27846E07 Q35952056-DE312B52-8DE6-4D96-B24D-B8F9827A8ABC Q36289377-3FDD92D6-4291-4FB5-89EA-95ABF2C4F670 Q36682372-E5985565-79A3-4022-8077-0031283387DB Q36852674-F84144DF-8E17-4D84-A68A-B1C7864FB733 Q37018397-828748D6-F7C6-4522-9B43-004C0F364517 Q37072227-CFDA0F7A-59BE-4E2F-A4E4-DFED23F0B47B Q37228375-1F10D9C6-C4B8-4239-B333-5949DBFF37C9 Q37542451-3D76E5C4-5D5C-4AD7-B05A-3B318C6B1008 Q37790755-1CB78AD1-17FC-470B-8620-FD01134EEA3F Q37962905-701009E6-705F-4CB3-B820-E6EC21F12179 Q38022543-8375575E-5C64-48C9-9AA9-29AC0448E1F6 Q38029769-42D216C5-3BB3-4184-B1F7-47524B8406DC Q38058243-5F85795B-43D4-4FC4-88DD-904D3BFB9B13 Q38161405-88245A95-AD49-4821-8482-6D8759C3D663 Q38723530-426639CD-F70B-4E2E-8C90-177E929566CB Q39147275-B789D225-BF54-4D37-80B3-1B8A2B6E6B1D Q39638770-8D6C7292-B884-41AB-A697-C59EB73A2E1C Q39643729-4049CECA-7CE2-4A92-9CDB-F7757499D886 Q41345228-A798233E-F4DF-43E9-9BD1-3BE238973223 Q41692560-7B3AE964-E5BB-47DD-9588-2A91CA60DEF9 Q42099510-BC4EC3DF-91E3-453D-B318-6C6B9952DE69

P2860

Plexin-B1 mutations in prostate cancer.

http://www.wikidata.org/entity/Q30480866

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Plexin-B1 mutations in prostate cancer.

@ast

Plexin-B1 mutations in prostate cancer.

@en

type

label

Plexin-B1 mutations in prostate cancer.

@ast

Plexin-B1 mutations in prostate cancer.

@en

prefLabel

Plexin-B1 mutations in prostate cancer.

@ast

Plexin-B1 mutations in prostate cancer.

@en

P1433

Q30480866-5F8D3E0B-9A35-443E-B060-1B30DF03E480

P1476

Q30480866-4B441691-B180-4CBA-922C-D22A93050EAB

P2093

Q30480866-11B44BF6-526E-47B1-8F76-95FDD2AC5DC7

Q30480866-22FC5090-8FEF-4F88-8378-994C2F6C9BDF

Q30480866-350D0B70-0B63-4BB1-8965-3394BD56CA58

Q30480866-42C59C20-7994-43B3-BBB4-822F22E6630E

Q30480866-43B46C4A-10F7-4E30-A3A6-C4B1DB8AD124

Q30480866-5B96880F-D864-44F9-89EC-A85FCC03AFF1

Q30480866-76793651-CF94-4BCB-B242-38F67E2250E8

Q30480866-8282D3DC-06EA-4150-8E28-12250676F6E9

Q30480866-B81B6278-B74D-4994-9393-788DCAABE0C8

Q30480866-BA72F74E-5610-4D30-9379-C16ADD199D3C

P2860

Q30480866-00ED9DF4-2C86-49AB-8C11-72FA2CB0EDA4

Q30480866-1621E400-EF14-434E-9892-3EAA10D6FBCB

Q30480866-1DB7DF38-7EF0-478F-BB49-8D60A0ED3F92

Q30480866-1E987F62-EA42-488B-B0CA-91470097A0B6

Q30480866-31CC4E88-3500-4648-9A90-C832F7FBE197

Q30480866-33C876C0-9D1E-4C41-8405-D9FBA7B812EF

Q30480866-35968650-67A9-45A4-B371-31F5408DD683

Q30480866-3692E04E-19B8-4C5C-AB8E-8BB66CDE552C

Q30480866-3917CF3D-50BF-4134-A1ED-43D176CB2AA2

Q30480866-3DA0C316-CED8-472E-BCB0-43C79900CBAA

P304

Q30480866-7BA613DC-BDA7-4CCA-A7BF-679AD7F9A16D

P31

Q30480866-6381B578-CBD8-46BB-841C-2BBEE8B36988

P356

Q30480866-D8B74CC0-9119-4F80-B65D-AF6112F3F780

P407

Q30480866-97CE8415-462B-4BFF-8402-808D17D6B2A8

P433

Q30480866-F023C52E-9EDA-472E-8581-33B7FB213149

P478

Q30480866-57527A63-38FC-4250-9E22-9AAD6DEDD91A

P577

Q30480866-774D875C-AEED-4CCF-A5F7-7CF82A5716E8

P5875

Q30480866-03943711-97AE-4FEA-8B47-D685C89333E1

P698

Q30480866-FDAC53B4-E6E6-4928-B019-5D29DD596E0B

P932

Q30480866-E08C332D-6489-45B1-BFBE-DBCA994038EA

P356

PNAS.0702544104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Plexin-B1 mutations in prostate cancer.

@en

P2093

Alex Freeman

http://www.w3.org/2001/XMLSchema#string

Chun Zhou

http://www.w3.org/2001/XMLSchema#string

Gary Box

http://www.w3.org/2001/XMLSchema#string

Helmut Klocker

http://www.w3.org/2001/XMLSchema#string

Izumi Oinuma

http://www.w3.org/2001/XMLSchema#string

Jason Constantinou

http://www.w3.org/2001/XMLSchema#string

John R Masters

http://www.w3.org/2001/XMLSchema#string

Joseph Nariculam

http://www.w3.org/2001/XMLSchema#string

Magali Williamson

http://www.w3.org/2001/XMLSchema#string

Manabu Negishi

http://www.w3.org/2001/XMLSchema#string

P2860

Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates

Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho activation by Plexin-B1 and induces cell contraction in COS-7 cells

A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor

The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding

Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2

The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner

Structure of the semaphorin-3A receptor binding module

Mutations of the BRAF gene in human cancer

The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules

Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors

P304

19040-19045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0702544104

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5821826

http://www.w3.org/2001/XMLSchema#string

P698

18024597

http://www.w3.org/2001/XMLSchema#string

P932

2141904

http://www.w3.org/2001/XMLSchema#string